NANOVIRICIDES, INC. Debt Conversion, Converted Instrument, Amount
NANOVIRICIDES, INC. (NNVC) reported Debt Conversion, Converted Instrument, Amount of $1.50 million for the 12-month period ending 2024-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2025-09-29
- NANOVIRICIDES, INC. debt conversion, converted instrument, amount for the quarter ending 2019-06-30 was $0.00.
- NANOVIRICIDES, INC. debt conversion, converted instrument, amount for the quarter ending 2018-06-30 was -$4.37M, a 187.50% decline year-over-year.
- NANOVIRICIDES, INC. debt conversion, converted instrument, amount for the quarter ending 2017-06-30 was $5.00M.
- NANOVIRICIDES, INC. debt conversion, converted instrument, amount for the quarter ending 2016-06-30 was $0.00.
- NANOVIRICIDES, INC. debt conversion, converted instrument, amount for fiscal 2024 was $1.50M.
- NANOVIRICIDES, INC. debt conversion, converted instrument, amount for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- NANOVIRICIDES, INC. debt conversion, converted instrument, amount for fiscal 2018 was $230.25K, a 95.39% decline from fiscal 2017.
- NANOVIRICIDES, INC. debt conversion, converted instrument, amount for fiscal 2017 was $5.00M.
| Period end | Debt Conversion, Converted Instrument, Amount 0 month | Debt Conversion, Converted Instrument, Amount 1 month | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 3 month as first filed | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 9 month as first filed | Debt Conversion, Converted Instrument, Amount 12 month | Debt Conversion, Converted Instrument, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | $1.50M 10-K · filed 2025-09-29 | ||||||||
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $0.00 10-K · filed 2020-10-13 | |||||||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 | ||||||||
| 2018-06-30 | -$4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $230.25K 10-K · filed 2020-10-13 | $4.61M 10-K · filed 2018-10-12 | ||||||
| 2018-03-31 | $4.61M 10-Q · filed 2019-05-15 | ||||||||
| 2017-06-30 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-23 | $5.00M 10-K · filed 2019-08-23 | |||||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-21 | $5.00M 10-Q · filed 2017-05-15 | |||||||
| 2017-02-08 | $24.27K 10-Q · filed 2017-05-15 | $24.27K 10-K · filed 2019-08-23 | |||||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | $0.00 derived: sum of 2 quarters · filed 2018-10-12 | $0.00 derived: sum of 3 quarters · filed 2018-10-12 | $0.00 10-K · filed 2018-10-12 | |||||
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $0.00 derived: sum of 2 quarters · filed 2017-05-15 | $0.00 10-Q · filed 2017-05-15 | $0.00 derived: sum of 4 quarters · filed 2017-05-15 | |||||
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | $0.00 10-Q · filed 2016-02-09 | $0.00 derived: sum of 3 quarters · filed 2016-09-16 | $0.00 derived: sum of 4 quarters · filed 2016-09-16 | |||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-09-16 | $0.00 derived: sum of 3 quarters · filed 2016-09-16 | -$494.31K derived: sum of 4 quarters · filed 2016-09-16 | |||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-16 | $0.00 derived: sum of 2 quarters · filed 2016-09-16 | -$494.31K derived: sum of 3 quarters · filed 2016-09-16 | $1.15M 10-K · filed 2016-09-16 | |||||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | -$494.31K derived: sum of 2 quarters · filed 2016-05-10 | $1.15M 10-Q · filed 2016-05-10 | $1.15M derived: sum of 4 quarters · filed 2016-09-16 | |||||
| 2014-12-31 | -$494.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | $1.15M 10-Q · filed 2016-02-09 | $1.15M derived: sum of 3 quarters · filed 2016-09-16 | $1.15M derived: sum of 4 quarters · filed 2016-09-16 | |||||
| 2014-09-30 | $1.65M 10-Q · filed 2015-11-09 | $1.65M 10-Q · filed 2014-11-14 | $1.65M derived: sum of 2 quarters · filed 2016-09-16 | $1.65M derived: sum of 3 quarters · filed 2016-09-16 | |||||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-16 | $0.00 derived: sum of 2 quarters · filed 2016-09-16 | $0.00 10-K · filed 2016-09-16 | ||||||
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $0.00 10-Q · filed 2015-05-15 | |||||||
| 2013-12-31 | $0.00 10-Q · filed 2015-02-25 | ||||||||
| 2013-06-30 | $0.00 10-K · filed 2015-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |